These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16651811)

  • 21. Gene expression in cerebral ischemia: a new approach for neuroprotection.
    Millán M; Arenillas J
    Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: the potential molecular mechanisms.
    Li Q; Zhuang QK; Yang JN; Zhang YY
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1113-26. PubMed ID: 24817284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
    Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
    Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
    Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Statins and brain protection mechanisms].
    Tapia-Perez H; Sanchez-Aguilar M; Torres-Corzo J; Rodriguez-Leyva I; Herrera-Gonzalez LB
    Rev Neurol; 2007 Sep 16-30; 45(6):359-64. PubMed ID: 17899518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preventive neuroprotection: from experimental data to therapeutic strategies].
    Bordet R
    Therapie; 2002; 57(6):540-7. PubMed ID: 12666261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression.
    Wang L; Zhang X; Liu L; Yang R; Cui L; Li M
    Neurosci Lett; 2010 Mar; 471(3):152-6. PubMed ID: 20100543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat.
    Kawai H; Deguchi S; Deguchi K; Yamashita T; Ohta Y; Omote Y; Kurata T; Ikeda Y; Matsuura T; Abe K
    Brain Res; 2011 Mar; 1382():308-14. PubMed ID: 21276424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
    Chłopicki S; Gryglewski RJ
    Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Consensus review. Pharmacological neuroprotection in cerebral ischemia: is it still a therapeutic option?].
    Castillo J; Alvarez-Sabin J; Dávalos A; Diez-Tejedor E; Lizasoain I; Martínez-Vila E; Vivancos J; Zarranz JJ
    Neurologia; 2003 Sep; 18(7):368-84. PubMed ID: 14505245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
    Wang H; Lynch JR; Song P; Yang HJ; Yates RB; Mace B; Warner DS; Guyton JR; Laskowitz DT
    Exp Neurol; 2007 Jul; 206(1):59-69. PubMed ID: 17521631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential roles for statins in critically ill patients.
    Weant KA; Cook AM
    Pharmacotherapy; 2007 Sep; 27(9):1279-96. PubMed ID: 17723082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of hydroalcoholic extract of Mimusops elengi Linn. flowers against middle cerebral artery occlusion induced brain injury in rats.
    Nagakannan P; Shivasharan BD; Thippeswamy BS; Veerapur VP; Bansal P
    J Ethnopharmacol; 2012 Mar; 140(2):247-54. PubMed ID: 22281124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targets for vascular protection after acute ischemic stroke.
    Fagan SC; Hess DC; Hohnadel EJ; Pollock DM; Ergul A
    Stroke; 2004 Sep; 35(9):2220-5. PubMed ID: 15284446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protecting neurons.
    Ferriero DM
    Epilepsia; 2005; 46 Suppl 7():45-51. PubMed ID: 16201995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin use before and after acute ischemic stroke onset improves neurological outcome.
    Salat D; Ribosa R; Garcia-Bonilla L; Montaner J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1219-30. PubMed ID: 19814665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
    Barone FC
    Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelium-targeted pharmacotherapeutics for the treatment of stroke.
    Danton G; Watson BD; Prado R; Dietric WD
    Curr Opin Investig Drugs; 2002 Jun; 3(6):896-904. PubMed ID: 12137409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.